Search

Vikas P Sukhatme

from Atlanta, GA
Age ~73

Vikas Sukhatme Phones & Addresses

  • 2503 Oak Grove Ests NE, Atlanta, GA 30345 (617) 244-7436
  • Northborough, MA
  • 1511 E 56Th St, Chicago, IL 60637 (312) 363-5538
  • 20 Wheeler Rd, Newton Center, MA 02459 (617) 244-7436
  • 36 Sky View Cir, Newton Center, MA 02459 (617) 244-7436
  • Newton, MA
  • Palo Alto, CA
  • 36 Sky View Cir, Newton, MA 02459 (617) 771-1767

Work

Company: Boston Office Address: 330 Brookline Ave, Boston, MA 02215 Phones: (617) 667-7000 (617) 667-9696

Education

School / High School: Harvard Med Sch 1979

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Internal Medicine, 1982

Specialities

Internal Medicine

Professional Records

Medicine Doctors

Vikas Sukhatme Photo 1

Dr. Vikas P Sukhatme, Boston MA - MD (Doctor of Medicine)

View page
Specialties:
Internal Medicine
Address:
330 Brookline Ave Suite 563, Boston, MA 02215
(617) 667-2105 (Phone), (617) 667-7843 (Fax)

Boston Office
330 Brookline Ave, Boston, MA 02215
(617) 667-7000 (Phone), (617) 667-9696 (Fax)

1511 E 56Th St, Chicago, IL 60637
Certifications:
Internal Medicine, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
330 Brookline Ave Suite 563, Boston, MA 02215

1511 E 56Th St, Chicago, IL 60637

Boston Office
330 Brookline Ave, Boston, MA 02215

Beth Israel Deaconess Medical Center
330 Brookline Avenue, Boston, MA 02215
Education:
Medical School
Harvard Med Sch
Graduated: 1979
Medical School
Massachusetts General Hospital
Graduated: 1979
Vikas Sukhatme Photo 2

Vikas Pandurang Sukhatme, Boston MA

View page
Specialties:
Internal Medicine
Nephrology
Work:
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston, MA 02215
Education:
Harvard University(1979)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Vikas Sukhatme
Chief Academic Officer
Beth Israel Deaconess Medical Center Inc
General Hospital · General Medical and Surgical Hospitals, Nsk
330 Brookline Ave, Boston, MA 02215
Vikas Sukhatme
Director
Ultimate Medical Information L
Health/Allied Services
25 Sky Vw Cir, Newton, MA 02459
Vikas P. Sukhatme
Treasurer
VS, INC
36 Skyview Cir, Newton, MA 02159

Publications

Us Patents

Combination Of Radiotherapy And Anti-Angiogenic Factors

View page
US Patent:
6420335, Jul 16, 2002
Filed:
Jun 16, 1999
Appl. No.:
09/334084
Inventors:
Ralph R. Weichselbaum - Chicago IL
Vikas P. Sukhatme - Newton MA
Donald W. Kufe - Wellesley MA
Assignee:
Dana Farber Cancer Institute, Inc. - Boston MA
ARCH Development Corporation - Chicago IL
Beth Israel Deaconess Medical Center, Inc. - Boston MA
International Classification:
A01N 3718
US Classification:
514 2, 530350, 378 65, 514 1, 600 1
Abstract:
The present invention relates generally to the fields of angiogenesis and cancer therapy. More particularly, it concerns the use of anti-angiogenic factors in cancer therapy. The present invention demonstrates that angiostatin or endostatin can sensitize a cell to radiation therapy. Methods and compositions for inhibiting growth, sensitizing a cell to radiotherapy and treating cancer growth by first inhibiting angiogenesis and then employing radiotherapy are described.

Gene Transcription And Ionizing Radiation: Methods And Compositions

View page
US Patent:
6605712, Aug 12, 2003
Filed:
Sep 11, 1992
Appl. No.:
07/943812
Inventors:
Ralph R. Weichselbaum - Chicago IL
Dennis E. Hallahan - Chicago IL
Vikas P. Sukhatme - Chicago IL
Donald W. Kufe - Wellesley MA
Assignee:
Arch Development Corporation - Chicago IL
International Classification:
C12N 1511
US Classification:
536 241, 424 9321, 4353201, 514 44
Abstract:
The present invention provides a DNA molecule comprising a radiation responsive enhancer-promoter operatively linked to an encoding region that encodes at least one polypeptide. An encoding region can comprise a single encoding sequence for a polypeptide or two or more encoding sequences encoding DNA binding, activation or repression domains of a transcription factor. Processes for regulating polypeptide expression and inhibiting tumor growth using such DNA molecules are also provided.

Methods Of Inhibiting Proliferative Diseases By Inhibiting Tgf--Mediated Angiogenesis

View page
US Patent:
6673341, Jan 6, 2004
Filed:
Jul 1, 1999
Appl. No.:
09/346179
Inventors:
Vikas P. Sukhatme - Newton Center MA
Assignee:
Beth Israel Deaconness Medical Center
International Classification:
A61K 39395
US Classification:
4241301, 4241451, 4241381
Abstract:
Disclosed are methods of inhibiting proliferative diseases characterized by TGF--mediated angiogenesis.

Methods Of Producing Anti-Angiogenic Proteins

View page
US Patent:
6797488, Sep 28, 2004
Filed:
Jun 7, 2000
Appl. No.:
09/589483
Inventors:
Vikas P. Sukhatme - Newton Center MA
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
International Classification:
C12P 2102
US Classification:
435 691, 435 696, 435483
Abstract:
Methods for making proteins with anti-angiogenic properties are disclosed. The system used is a yeast expression system which produces biologically active proteins at high titer.

Anti-Angiogenic Peptides And Methods Of Use Thereof

View page
US Patent:
6852691, Feb 8, 2005
Filed:
Jun 8, 2000
Appl. No.:
09/589777
Inventors:
Vikas P. Sukhatme - Newton Center MA, US
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
International Classification:
A61K038/00
C07K014/00
US Classification:
514 12, 530536, 530350
Abstract:
EM 1, a novel anti-angiogenic protein, and a deletion mutant of endostatin, is described, as well as methods of making EM1, therapeutic compositions comprising EM1, and methods for using those compositions.

Gene Transcription And Ionizing Radiation: Methods And Compositions

View page
US Patent:
7041653, May 9, 2006
Filed:
Dec 5, 2000
Appl. No.:
09/730630
Inventors:
Ralph R. Weichselbaum - Chicago IL, US
Dennis E. Hallahan - Chicago IL, US
Vikas P. Sukhatme - Chicago IL, US
Donald W. Kufe - Wellesley MA, US
Assignee:
The University of Chicago - Chicago IL
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A01N 43/04
A01N 63/00
C07H 21/02
C07H 21/04
C12N 15/63
US Classification:
514 44, 536 231, 536 235, 536 241, 424 931, 424 932, 435455
Abstract:
The present invention provides a DNA molecule comprising a radiation responsive enhancer-promoter operatively linked to an encoding region that encodes at least one polypeptide. An encoding region can comprise a single encoding sequence for a polypeptide or two or more encoding sequences encoding DNA binding, activation or repression domains of a transcription factor. Processes for regulating polypeptide expression and inhibiting tumor growth using such DNA molecules are also provided.

Methods Of Treating Pre-Eclampsia Or Eclampsia

View page
US Patent:
7335362, Feb 26, 2008
Filed:
Feb 4, 2004
Appl. No.:
10/771518
Inventors:
S. Ananth Karumanchi - West Roxbury MA, US
Sharon Maynard - Newton MA, US
Vikas P. Sukhatme - Newton MA, US
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
International Classification:
A61K 38/00
A61K 39/00
G01N 33/53
C07K 17/00
US Classification:
4241981, 435 71, 435 72, 514 2, 514 12, 530350
Abstract:
Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1- are also disclosed herein for the treatment of pre-eclampsia or eclampsia.

Methods Of Diagnosing Pre-Eclampsia Or Eclampsia

View page
US Patent:
7407659, Aug 5, 2008
Filed:
Jul 21, 2003
Appl. No.:
10/624809
Inventors:
S. Ananth Karumanchi - West Roxbury MA, US
Sharon Maynard - Newton MA, US
Vikas P. Sukhatme - Newton MA, US
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
International Classification:
A61K 38/00
A61K 39/00
G01N 33/53
C07K 17/00
US Classification:
4241981, 435 71, 435 72, 514 2, 514 12, 530350
Abstract:
Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1—are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
Vikas P Sukhatme from Atlanta, GA, age ~73 Get Report